Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Endometriosis Treatment Market by Type (Hormonal Contraceptives, Gonadotropin-releasingHormone(Gn-RH)Agonists, Progestin Therapy, Aromatase Inhibitors), By Application (Hospital, Clinic, Other) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Endometriosis Treatment Market by Type (Hormonal Contraceptives, Gonadotropin-releasingHormone(Gn-RH)Agonists, Progestin Therapy, Aromatase Inhibitors), By Application (Hospital, Clinic, Other) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 325668 4200 Pharma & Healthcare 377 218 Pages 4.8 (46)
                                          

Market Overview:


The global endometriosis treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as the increasing prevalence of endometriosis, technological advancements in the field of endometriosis treatment, and rising awareness about available treatments for endometriosis. The global endometriosis treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into hormonal contraceptives, gonadotropin-releasing hormone (Gn-RH) agonists, progestin therapy, and aromatase inhibitors. Hormonal contraceptives are further subsegmented into oral contraceptives and injectable contraceptives. Gn-RH agonists are further subsegmented into leuprolide acetate depot injection and goserelin acetate implantation kit.


Global Endometriosis Treatment Industry Outlook


Product Definition:


Endometriosis Treatment is a medical procedure that is used to treat endometriosis. Endometriosis Treatment may include surgery, medication, or other treatments.


Hormonal Contraceptives:


Hormonal contraceptives are drugs that act as a barrier between the sperm and ovum. The most commonly used hormonal contraceptive drug is oral contraception, which includes pills, implants, and intra-uterine devices (IUD). Hormonal therapy also includes hormone replacement therapy for women who have undergone surgical sterilization or who have experienced post-surgical bleeding.


The global hormonal contraceptives market size was valued at USD 6.6 billion in 2015.


Gonadotropin-releasingHormone(Gn-RH)Agonists:


Gonadotropin-releasing hormone (Gn-RH) agonists are a group of drugs that act on the pituitary gland to release luteinizing hormone (LH). It is used in the treatment of endometriosis. Endometriosis is a condition where tissues found inside the uterus grow outside of it, causing severe pain and damage to fertility.


Application Insights:


Based on application, the global endometriosis treatment market is segmented into hospital, clinic and others. The other applications include online therapy and self-treatment at home. Hospital was the largest application segment in 2017 owing to its wide scope of treatment including surgery, chemotherapy and medical procedures that require a large number of patients for research studies or trials.


Hospital based clinics are preferred by women who cannot travel due to social conditions such as financial burden or distance between their place of residence and hospitals.


Regional Analysis:


North America dominated the global endometriosis treatment market in 2017. The presence of well-established healthcare facilities, high awareness levels pertaining to the symptoms associated with endometriosis, and increasing government initiatives are some of the major factors responsible for its large share. For instance, in October 2016, Fertility Health International (FHI), a nonprofit organization focused on women’s health issues conducted an educational program about Endometriosis and fertility among women living across North America.


Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to unmet needs regarding effective treatments for this disease coupled with rapidly improving healthcare infrastructure and growing medical research activities in this region. In addition, rising disposable income levels are also anticipated to contribute towards market growth over the next few years. Moreover, an increase in immigration from developed countries such as U.S.


Growth Factors:


  • Rising incidence of endometriosis
  • Growing awareness about the disease and its treatment options
  • Increasing number of research and development activities for new endometriosis treatments
  • Availability of government funding for endometriosis research projects
  • Growing demand for minimally invasive surgical procedures for treating endometriosis

Scope Of The Report

Report Attributes

Report Details

Report Title

Endometriosis Treatment Market Research Report

By Type

Hormonal Contraceptives, Gonadotropin-releasingHormone(Gn-RH)Agonists, Progestin Therapy, Aromatase Inhibitors

By Application

Hospital, Clinic, Other

By Companies

AbbVie, Eli Lilly, AstraZeneca, Bayer, Astellas Pharma, Meditrina Pharmaceuticals, Pfizer, Neurocrine Biosciences, Takeda Pharmaceutical

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

218

Number of Tables & Figures

153

Customization Available

Yes, the report can be customized as per your need.


Global Endometriosis Treatment Market Report Segments:

The global Endometriosis Treatment market is segmented on the basis of:

Types

Hormonal Contraceptives, Gonadotropin-releasingHormone(Gn-RH)Agonists, Progestin Therapy, Aromatase Inhibitors

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Clinic, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. AbbVie
  2. Eli Lilly
  3. AstraZeneca
  4. Bayer
  5. Astellas Pharma
  6. Meditrina Pharmaceuticals
  7. Pfizer
  8. Neurocrine Biosciences
  9. Takeda Pharmaceutical

Global Endometriosis Treatment Market Overview


Highlights of The Endometriosis Treatment Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Hormonal Contraceptives
    2. Gonadotropin-releasingHormone(Gn-RH)Agonists
    3. Progestin Therapy
    4. Aromatase Inhibitors
  1. By Application:

    1. Hospital
    2. Clinic
    3. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Endometriosis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Endometriosis Treatment Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Endometriosis treatment may include surgery, medication, and/or radiation therapy. Surgery is the most common form of endometriosis treatment. It can involve removing the affected tissue or parts of the uterus (womb). Medication may be used to stop pain and inflammation. Radiation therapy can help destroy cancer cells that are associated with endometriosis.

Some of the major companies in the endometriosis treatment market are AbbVie, Eli Lilly, AstraZeneca, Bayer, Astellas Pharma, Meditrina Pharmaceuticals, Pfizer, Neurocrine Biosciences, Takeda Pharmaceutical.

The endometriosis treatment market is expected to grow at a compound annual growth rate of 7.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Endometriosis Treatment Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Endometriosis Treatment Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Endometriosis Treatment Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Endometriosis Treatment Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Endometriosis Treatment Market Size & Forecast, 2020-2028       4.5.1 Endometriosis Treatment Market Size and Y-o-Y Growth       4.5.2 Endometriosis Treatment Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 Hormonal Contraceptives
      5.2.2 Gonadotropin-releasingHormone(Gn-RH)Agonists
      5.2.3 Progestin Therapy
      5.2.4 Aromatase Inhibitors
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Hospital
      6.2.2 Clinic
      6.2.3 Other
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Endometriosis Treatment Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Endometriosis Treatment Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 Hormonal Contraceptives
      9.6.2 Gonadotropin-releasingHormone(Gn-RH)Agonists
      9.6.3 Progestin Therapy
      9.6.4 Aromatase Inhibitors
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Hospital
      9.10.2 Clinic
      9.10.3 Other
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 Hormonal Contraceptives
      10.6.2 Gonadotropin-releasingHormone(Gn-RH)Agonists
      10.6.3 Progestin Therapy
      10.6.4 Aromatase Inhibitors
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Hospital
      10.10.2 Clinic
      10.10.3 Other
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 Hormonal Contraceptives
      11.6.2 Gonadotropin-releasingHormone(Gn-RH)Agonists
      11.6.3 Progestin Therapy
      11.6.4 Aromatase Inhibitors
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Hospital
      11.10.2 Clinic
      11.10.3 Other
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 Hormonal Contraceptives
      12.6.2 Gonadotropin-releasingHormone(Gn-RH)Agonists
      12.6.3 Progestin Therapy
      12.6.4 Aromatase Inhibitors
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Hospital
      12.10.2 Clinic
      12.10.3 Other
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 Hormonal Contraceptives
      13.6.2 Gonadotropin-releasingHormone(Gn-RH)Agonists
      13.6.3 Progestin Therapy
      13.6.4 Aromatase Inhibitors
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Hospital
      13.10.2 Clinic
      13.10.3 Other
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Endometriosis Treatment Market: Competitive Dashboard
   14.2 Global Endometriosis Treatment Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 AbbVie
      14.3.2 Eli Lilly
      14.3.3 AstraZeneca
      14.3.4 Bayer
      14.3.5 Astellas Pharma
      14.3.6 Meditrina Pharmaceuticals
      14.3.7 Pfizer
      14.3.8 Neurocrine Biosciences
      14.3.9 Takeda Pharmaceutical

Our Trusted Clients

Contact Us